-
Walgreens Is 'Poorly Positioned' In The Evolving Retail Pharmacy Space, Cowen Says
Monday, July 23, 2018 - 1:47pm | 439Read More...Walgreens Boots Alliance Inc (NASDAQ: WBA), the newest member of the Dow Jones Industrial Average, is "poorly positioned" within the evolving retail pharmacy space, according to Cowen. The Analyst Charles Rhyee downgraded Walgreens Boots Alliance from Outperform to Market Perform with a...
-
AmerisourceBergen Falls As Walgreens Deal Appears Off The Table; Cowen Says Buy The Dip
Tuesday, February 27, 2018 - 3:19pm | 385Read More...AmerisourceBergen Corp. (NYSE: ABC) shares plunged Tuesday following a CNBC report it ended merger talks with Walgreens Boots Alliance Inc (NASDAQ: WBA) without reaching a deal. One Street analyst remained a buyer amid the pullback. The Rating Cowen analyst Charles Rhyee reiterated an...
-
Amazon's Pharma Aspirations: Cowen Finds No New License Applications
Friday, January 19, 2018 - 12:37pm | 434Read More...Is Amazon.com, Inc. (NASDAQ: AMZN) looking to enter the pharmacy space? A review of statewide pharmacy licenses answers the pressing question, according to Cowen. The Analyst Cowen's Charles Rhyee does not directly cover Amazon's stock. The firm has an Outperform rating...
-
4 Reasons You Can Expect Allscripts To Outperform
Monday, September 11, 2017 - 10:49am | 449Read More...Analysts at Cowen highlighted four reasons why investors should consider buying Allscripts Healthcare Solutions Inc (NASDAQ: MDRX). The firm's Charles Rhyee upgraded Allscripts' stock rating from Market Perform to Outperform with a price target raised from $13 to $16. 1. Improving...
-
What The Street Gets Wrong About Evolent Health, Cowen's 'Best Small-Mid Cap Idea'
Tuesday, June 27, 2017 - 3:01pm | 424Read More...Evolent Health Inc (NYSE: EVH), a provider of an end-to-end, technology-enabled services platform for healthcare providers, is an underappreciated stock that is best positioned to capitalize on the evolving healthcare landscape, analysts at Cowen stated in a research report. Cowen's Charles Rhyee...
-
Cowen Downgrades Cardinal Health, McKesson Amid Limited Near-Term Growth Drivers
Tuesday, March 15, 2016 - 8:42am | 366Read More...Cowen & Company’s Charles Rhyee downgraded the ratings for Cardinal Health Inc (NYSE: CAH) and McKesson Corporation (NYSE: MCK) from Outperform to Market Perform, citing continued headwinds from declining generic introductions and reversal of generic inflation to deflation. Analyst...
-
Walgreens-Rite Aid Synergies May Be Better Than Expected, Says Analyst
Wednesday, October 28, 2015 - 9:25am | 297Read More...Walgreens Boots Alliance Inc (NASDAQ: WBA) shares have gained 10 percent in the past six months, amid high volatility. Cowen & Co’s Charles Rhyee maintained an Outperform rating on the company, with a price target of $102. The acquisition of Rite Aid Corporation (NYSE: RAD)...
-
'Attractive Entry Points' In WebMD And Everyday Health Following Clinton's Sell-Off Plan
Wednesday, September 23, 2015 - 1:29pm | 485Read More...Cowen believes that the selloff in WebMD Health Corp. (NASDAQ: WBMD) and Everyday Health Inc (NYSE: EVDY) following Hillary Clinton’s drug pricing plan is overdone. If implemented, the plan could serve to reduce the advertising budgets of many pharma companies. Cowen’s long-term...
-
WebMD Is Quickly Becoming A Wall Street Favorite
Thursday, September 17, 2015 - 8:07am | 305Read More...WebMD Health Corp. (NASDAQ: WBMD) gained 5.4 percent in the last five trading sessions. Charles Rhyee of Cowen and Company upgraded WebMD to Outperform and hiked its price target to $53 from $42 prior. Rhyee said that WebMD is poised to transform into a "broader healthcare service...
-
Cowen Upgrades Walgreens: Here's Why
Wednesday, September 9, 2015 - 2:33pm | 413Read More...Shares of Walgreens Boots Alliance Inc (NASDAQ: WBA) traded higher after Wednesday's market open, but gave up its gains despite an upgrade by analysts at Cowen. In a report published Wednesday, Cowen and Company analyst Charles Rhyee upgraded Walgreens to Outperform from Market Perform with a...
-
2 Analysts Discuss Why Express Scripts Could Lose From A Humana Takeover
Monday, June 1, 2015 - 10:10am | 522Read More...Shares of Humana Inc (NYSE: HUM) soared higher on Friday after reports surfaced that the company hired bankers to evaluate a sale of itself. Analysts at Stifel suggested a $230 to $240 per share price tag on any deal. On Monday, analysts at both Cowen and Raymond James discussed why a possible...
-
Oppenheimer Lowers athenahealth Price Target
Friday, July 16, 2010 - 1:44pm | 138Read More...Oppenheimer lowered its estimates and price target for athenahealth, Inc (NASDAQ: ATHN). athenahealth is a provider of Internet-based solutions for physicians. Oppenheimer analyst Charles Rhyee said, "With recent evidence of athenaClinicals gaining traction, we cautiously increase our expectation...
-
McKesson Corporation (MCK) Maintains An Outperform Rating
Friday, February 12, 2010 - 6:08pm | 119Read More...Analyst Charles Rhyee at Oppenheimer (NYSE: OPY) has maintained an Outperform rating for McKesson Corporation (NYSE: MCK). The company currently has $3.4 billion in cash, which Oppenheimer believes it can use for acquisitions or share repurchases. According to Oppenheimer, the market has not...
